Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Uchida

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vectorNaoya Uchida, Phillip W Hargrove, Coen J Lap, et al.
Blood|October 24, 2015
Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging studyRobert E Donahue, Sharat Srinivasula, Naoya Uchida, et al.
Cell Stem Cell|April 9, 2011
Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant modelsWolfram Goessling, Robyn S Allen, Xiao Guan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2013
No impact of lentiviral transduction on hematopoietic stem/progenitor cell telomere length or gene expression in the rhesus macaque modelStephanie E Sellers, Bogdan Dumitriu, Mary J Morgan, et al.
Blood Advances|October 28, 2025
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine modelHenna Butt, Shruti Sathish, Evan London, et al.
Cytotherapy|March 20, 2024
Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse modelsSelami Demirci, Muhammad B N Khan, Gabriela Hinojosa, et al.
Cell Reports. Medicine|May 5, 2021
Preclinical evaluation for engraftment of CD34<sup>+</sup> cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate modelsNaoya Uchida, Linhong Li, Tina Nassehi, et al.
Science Translational Medicine|April 29, 2021
Sustained fetal hemoglobin induction in vivo is achieved by <i>BCL11A</i> interference and coexpressed truncated erythropoietin receptorNaoya Uchida, Francesca Ferrara, Claire M Drysdale, et al.
Blood Advances|December 22, 2020
Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque modelKate Stringaris, Robert F Hoyt, Jan K Davidson-Moncada, et al.
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Pre-existing immunity does not impair the engraftment of CRISPR-Cas9-edited cells in rhesus macaques conditioned with busulfan or radiationKhaled Essawi, Waleed Hakami, Muhammad Behroz Naeem Khan, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vectorNaoya Uchida, Phillip W Hargrove, Coen J Lap, et al.
Blood|October 24, 2015
Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging studyRobert E Donahue, Sharat Srinivasula, Naoya Uchida, et al.
Cell Stem Cell|April 9, 2011
Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant modelsWolfram Goessling, Robyn S Allen, Xiao Guan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2013
No impact of lentiviral transduction on hematopoietic stem/progenitor cell telomere length or gene expression in the rhesus macaque modelStephanie E Sellers, Bogdan Dumitriu, Mary J Morgan, et al.
Blood Advances|October 28, 2025
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine modelHenna Butt, Shruti Sathish, Evan London, et al.
Cytotherapy|March 20, 2024
Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse modelsSelami Demirci, Muhammad B N Khan, Gabriela Hinojosa, et al.
Cell Reports. Medicine|May 5, 2021
Preclinical evaluation for engraftment of CD34<sup>+</sup> cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate modelsNaoya Uchida, Linhong Li, Tina Nassehi, et al.
Science Translational Medicine|April 29, 2021
Sustained fetal hemoglobin induction in vivo is achieved by <i>BCL11A</i> interference and coexpressed truncated erythropoietin receptorNaoya Uchida, Francesca Ferrara, Claire M Drysdale, et al.
Blood Advances|December 22, 2020
Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque modelKate Stringaris, Robert F Hoyt, Jan K Davidson-Moncada, et al.
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Pre-existing immunity does not impair the engraftment of CRISPR-Cas9-edited cells in rhesus macaques conditioned with busulfan or radiationKhaled Essawi, Waleed Hakami, Muhammad Behroz Naeem Khan, et al.
Pageof 9